Professor Jae Young Choi received his B.A., M.A. and Ph.D. from Yonsei University in Seoul and is currently working as a professor at the Department of Congenital Heart at Cardiovascular Hospital, Severance Hospital, Yonsei University.
He has published widely on the subjects of congenital heart disease intervention and pulmonary arterial hypertension. Recently, a study on Selexipag, a pulmonary arterial hypertension drug, was published in the "Congenital Heart Disease" journal.
A study on transcatheter asd device closure was published in the "Korean Circulation Journal."
Professor Jae Young Choi received his B.A., M.A. and Ph.D. from Yonsei University in Seoul and is currently working as a professor at the Department of Congenital Heart at Cardiovascular Hospital, Severance Hospital, Yonsei University.
He has published widely on the subjects of congenital heart disease intervention and pulmonary arterial hypertension. Recently, a study on Selexipag, a pulmonary arterial hypertension drug, was published in the "Congenital Heart Disease" journal.
A study on transcatheter asd device closure was published in the "Korean Circulation Journal."